The Bottom Line cover image

Blockbuster drugs

The Bottom Line

00:00

AI, Data Analysis, and Drug Development

This chapter explores the use of AI and data analysis in drug development, discussing the challenges posed by monogenic and common diseases. It delves into the business side of drug development, including high costs, risks, and pricing strategies. The chapter also examines the impact of patent expiration on drug companies and the pricing of drugs, as well as the high cost of upcoming gene therapy and gene editing drugs.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app